Table 2.
Diagnostic procedures within 12 mo after the index date, n (%)
|
Diagnostic procedure
|
Patients with APPM and liver disease: APPM cohort, n = 2680
|
| Imaging procedure1 | 1778 (66.3) |
| Laboratory test2 | 1366 (51.0) |
| Liver biopsy | 207 (7.7) |
| AAT phenotyping | 55 (2.1) |
| Liver function test3 | 13 (0.5) |
Data are n (%).
1
Included sonographies, computed tomography scans, magnetic resonance imaging procedures, angiographies of the abdomen and magnetic resonance elastographies.
2
Included albumin and bilirubin measurements.
3
Liver function test with intravenous application of a 13C-labeled substrate.
AAT: Alpha-1 antitrypsin; APPM: Alterations in plasma protein metabolism.